Literature DB >> 4076080

Relationship of aluminum to Alzheimer's disease.

D P Perl.   

Abstract

Alzheimer's disease is a progressive degenerative brain disease of unknown etiology, characterized by the development of large numbers of neurofibrillary tangles and senile plaques in the brain. Aluminum salts may be used experimentally to produce lesions which are similar, but not identical, to the neurofibrillary tangle. Although some studies have reported increased amounts of aluminum in the brains of Alzheimer's disease victims, these bulk analysis studies have been difficult to replicate and remain controversial. Using scanning electron microscopy with X-ray spectrometry, we have investigated this question on the cellular level. We have identified abnormal accumulations of aluminum within neurons derived from Alzheimer's disease patients containing neurofibrillary tangles. Similar accumulations have been detected in the numerous neurofibrillary tangle-bearing neurons seen in the brains of the indigenous native population of the island of Guam who suffer from amyotrophic lateral sclerosis and parkinsonism with dementia. Epidemiologic evidence strongly suggests a causal role for local environmental conditions relating to availability of aluminum, calcium, and magnesium. In view of the fact that a major consequence of acid rain is the liberation of large amounts of aluminum in bioavailable forms, concerns are raised about possible human health risks of this environmental phenomenon.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4076080      PMCID: PMC1568482          DOI: 10.1289/ehp.8563149

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  33 in total

1.  EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION 2. ELECTRON MICROSCOPY, PHOSPHATASE HISTOCHEMISTRY AND ELECTRON PROBE ANALYSIS.

Authors:  R D TERRY; C PENA
Journal:  J Neuropathol Exp Neurol       Date:  1965-04       Impact factor: 3.685

2.  EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION. I. LIGHT MICROSCOPIC OBSERVATIONS.

Authors:  I KLATZO; H WISNIEWSKI; E STREICHER
Journal:  J Neuropathol Exp Neurol       Date:  1965-04       Impact factor: 3.685

3.  Paired helical filaments in electron microscopy of Alzheimer's disease.

Authors:  M KIDD
Journal:  Nature       Date:  1963-01-12       Impact factor: 49.962

4.  Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features.

Authors:  A HIRANO; N MALAMUD; L T KURLAND
Journal:  Brain       Date:  1961-12       Impact factor: 13.501

5.  The pathogenesis of amyotrophic lateral sclerosis.

Authors:  Y Yase
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

6.  Neurofibrillary pathology.

Authors:  H Wiśniewski; R D Terry; A Hirano
Journal:  J Neuropathol Exp Neurol       Date:  1970-04       Impact factor: 3.685

7.  Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam.

Authors:  R M Garruto; R Yanagihara; D C Gajdusek
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

8.  Amyotrophic lateral sclerosis. A comparison of Guam and classical cases.

Authors:  A Hirano; N Arumugasamy; H M Zimmerman
Journal:  Arch Neurol       Date:  1967-04

9.  Alzheimer's disease: a study of epidemiological aspects.

Authors:  A Heyman; W E Wilkinson; J A Stafford; M J Helms; A H Sigmon; T Weinberg
Journal:  Ann Neurol       Date:  1984-04       Impact factor: 10.422

10.  Amyloid-like (Congophilic) neurofibrillary tangles do not react with neurofilament antisera in Alzheimer's cerebral cortex.

Authors:  A Bignami; D J Selkoe; D Dahl
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

View more
  21 in total

1.  The effects of aluminum ions on the phosphorylation of tubulin and microtubule proteins in the brain.

Authors:  P N Shevtsov; G S Burbaeva
Journal:  Neurosci Behav Physiol       Date:  2001 Mar-Apr

2.  Review of epidemiologic studies of aluminium and neurological disorders.

Authors:  G F Craun
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

3.  Twenty-six week toxicity study with KASAL® (basic sodium aluminum phosphate) in beagle dogs.

Authors:  J C Pettersen; D S Hackett; G M Zwicker; G L Sprague
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

4.  Environmental effects of aluminium.

Authors:  B O Rosseland; T D Eldhuset; M Staurnes
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

5.  Voltage gating in VDAC is markedly inhibited by micromolar quantities of aluminum.

Authors:  E T Dill; M J Holden; M Colombini
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

6.  Interaction of synthetic Alzheimer beta-protein-derived analogs with aqueous aluminum: a low-field 27Al NMR investigation.

Authors:  S B Vyas; L K Duffy
Journal:  J Protein Chem       Date:  1995-11

7.  The interaction of aluminium with soluble protein kinase C from mouse brain.

Authors:  H Katsuyama; K Saijoh; Y Inoue; K Sumino
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

8.  Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease.

Authors:  R Etcheberrigaray; E Ito; K Oka; B Tofel-Grehl; G E Gibson; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

9.  The solubilization of model Alzheimer tangles: reversing the beta-sheet conformation induced by aluminum with silicates.

Authors:  G D Fasman; C D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders.

Authors:  P R Hof; E A Nimchinsky; V Buée-Scherrer; L Buée; J Nasrallah; A F Hottinger; D P Purohit; A J Loerzel; J C Steele; A Delacourte
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.